Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16,463,909
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
33,297,098
-
Shares change
-
+1,253,755
-
Total reported value, excl. options
-
$610,504,496
-
Value change
-
+$19,762,513
-
Put/Call ratio
-
5%
-
Number of buys
-
60
-
Number of sells
-
-43
-
Price
-
$18.35
Significant Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) as of Q1 2023
125 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2023.
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33,297,098 shares
.
Largest 10 shareholders include FMR LLC (4,455,840 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,315,870 shares), Column Group LLC (2,680,621 shares), PERCEPTIVE ADVISORS LLC (2,291,608 shares), BlackRock Inc. (2,171,704 shares), STATE STREET CORP (1,639,046 shares), VANGUARD GROUP INC (1,581,518 shares), GREAT POINT PARTNERS LLC (1,355,151 shares), ORBIMED ADVISORS LLC (1,251,070 shares), and T. Rowe Price Investment Management, Inc. (1,231,783 shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.